O	O	O	0	10	Regulation	Regulation	B-NP	NN	O	0	ROOT	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	B-Protein	14	17	jun	jun	B-NP	NN	B-DNA	7	NMOD	B-DNA
O	O	O	18	21	and	and	I-NP	CC	I-DNA	7	NMOD	I-DNA
T2	B-Protein	B-Protein	22	25	fos	fos	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	O	26	30	gene	gene	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	O	31	41	expression	expression	I-NP	NN	O	2	PMOD	O
O	O	O	42	44	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	45	50	human	human	B-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	O	51	60	monocytes	monocyte	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	O	61	63	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	64	67	the	the	B-NP	DT	O	17	NMOD	O
T17	B-Entity	B-Entity	68	78	macrophage	macrophage	I-NP	NN	B-protein	17	NMOD	B-protein
T17	I-Entity	I-Entity	79	85	colony	colony	I-NP	NN	I-protein	17	NMOD	I-protein
T17	I-Entity	I-Entity	85	86	-	-	O	HYPH	I-protein	17	NMOD	I-protein
T17	I-Entity	I-Entity	86	97	stimulating	stimulate	B-VP	VBG	I-protein	17	NMOD	I-protein
T17	I-Entity	I-Entity	98	104	factor	factor	B-NP	NN	I-protein	11	PMOD	I-protein
O	O	O	104	105	.	.	O	.	O	1	P	O

O	O	O	107	110	The	The	B-NP	DT	O	6	NMOD	O
T18	B-Entity	B-Entity	111	121	macrophage	macrophage	I-NP	NN	B-protein	6	NMOD	B-protein
T18	I-Entity	I-Entity	122	128	colony	colony	I-NP	NN	I-protein	6	NMOD	I-protein
T18	I-Entity	I-Entity	128	129	-	-	O	HYPH	I-protein	6	NMOD	I-protein
T18	I-Entity	I-Entity	129	140	stimulating	stimulate	B-VP	VBG	I-protein	6	NMOD	I-protein
T18	I-Entity	I-Entity	141	147	factor	factor	B-NP	NN	I-protein	12	SUB	I-protein
O	O	O	148	149	(	(	O	(	O	11	DEP	O
T19	B-Entity	B-Entity	149	150	M	M	B-NP	NN	O	10	NMOD	O
T19	I-Entity	I-Entity	150	151	-	-	B-NP	HYPH	O	10	P	O
T19	I-Entity	I-Entity	151	154	CSF	CSF	I-NP	NN	B-protein	11	DEP	B-protein
O	O	O	154	155	)	)	O	)	O	6	NMOD	O
O	O	O	156	158	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	159	167	required	require	I-VP	VBN	O	12	VC	O
O	O	O	168	171	for	for	B-PP	IN	O	13	VMOD	O
O	O	O	172	175	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	176	182	growth	growth	B-NP	NN	O	18	NMOD	O
O	O	O	183	186	and	and	O	CC	O	18	NMOD	O
O	O	O	187	202	differentiation	differentiation	B-NP	NN	O	14	PMOD	O
O	O	O	203	205	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	206	217	mononuclear	mononuclear	B-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	O	218	228	phagocytes	phagocyte	I-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	O	228	229	.	.	O	.	O	12	P	O

O	O	O	230	237	However	However	B-ADVP	RB	O	10	VMOD	O
O	O	O	237	238	,	,	O	,	O	10	P	O
O	O	O	239	242	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	243	252	signaling	signaling	I-NP	NN	O	5	NMOD	O
O	O	O	253	259	events	event	I-NP	NNS	O	10	SUB	O
O	O	O	260	271	responsible	responsible	B-ADJP	JJ	O	5	NMOD	O
O	O	O	272	275	for	for	B-PP	IN	O	6	AMOD	O
O	O	O	276	281	these	these	B-NP	DT	O	9	NMOD	O
O	O	O	282	289	effects	effect	I-NP	NNS	O	7	PMOD	O
O	O	O	290	296	remain	remain	B-VP	VBP	O	0	ROOT	O
O	O	O	297	304	unclear	unclear	B-ADJP	JJ	O	10	PRD	O
O	O	O	304	305	.	.	O	.	O	10	P	O

O	O	O	306	309	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	310	317	present	present	I-NP	JJ	O	3	NMOD	O
O	O	O	318	325	studies	study	I-NP	NNS	O	4	SUB	O
O	O	O	326	330	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	331	339	examined	examine	I-VP	VBN	O	4	VC	O
O	O	O	340	343	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	344	351	effects	effect	I-NP	NNS	O	5	OBJ	O
O	O	O	352	354	of	of	B-PP	IN	O	7	NMOD	O
T20	B-Entity	B-Entity	355	356	M	M	B-NP	NN	O	11	NMOD	O
T20	I-Entity	I-Entity	356	357	-	-	B-NP	HYPH	O	11	NMOD	O
T20	I-Entity	I-Entity	357	360	CSF	CSF	I-NP	NN	B-protein	8	PMOD	B-protein
O	O	O	361	363	on	on	B-PP	IN	O	7	NMOD	O
O	O	O	364	373	potential	potential	B-NP	JJ	O	15	NMOD	O
O	O	O	374	383	signaling	signaling	I-NP	NN	O	15	NMOD	O
O	O	O	384	392	pathways	pathway	I-NP	NNS	O	12	PMOD	O
O	O	O	393	402	involving	involve	B-VP	VBG	O	15	NMOD	O
O	O	O	403	413	expression	expression	B-NP	NN	O	16	OBJ	O
O	O	O	414	416	of	of	B-PP	IN	O	17	NMOD	O
O	O	O	417	420	the	the	O	DT	O	25	NMOD	O
T3	B-Protein	B-Protein	421	424	jun	jun	B-NP	NN	B-DNA	22	NMOD	B-DNA
O	O	O	425	428	and	and	O	CC	I-DNA	22	NMOD	I-DNA
T4	B-Protein	B-Protein	429	432	fos	fos	B-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	O	433	438	early	early	B-NP	JJ	I-DNA	25	NMOD	I-DNA
O	O	O	439	447	response	response	I-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	O	448	453	genes	gene	I-NP	NNS	I-DNA	18	PMOD	I-DNA
O	O	O	453	454	.	.	O	.	O	4	P	O

O	O	O	455	458	Low	Low	B-NP	JJ	O	2	NMOD	O
O	O	O	459	465	levels	level	I-NP	NNS	O	8	SUB	O
O	O	O	466	468	of	of	B-PP	IN	O	2	NMOD	O
T5	B-Protein	B-Protein	469	470	c	c	B-NP	NN	O	7	NMOD	O
T5	I-Protein	I-Protein	470	471	-	-	I-NP	HYPH	O	7	NMOD	O
T5	I-Protein	I-Protein	471	474	jun	jun	I-NP	NN	B-RNA	7	NMOD	B-RNA
O	O	O	475	486	transcripts	transcript	I-NP	NNS	I-RNA	3	PMOD	I-RNA
O	O	O	487	491	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	492	502	detectable	detectable	B-ADJP	JJ	O	8	PRD	O
O	O	O	503	505	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	506	513	resting	rest	B-NP	VBG	B-cell_type	15	NMOD	B-cell_type
O	O	O	514	519	human	human	I-NP	JJ	I-cell_type	15	NMOD	I-cell_type
O	O	O	520	530	peripheral	peripheral	I-NP	JJ	I-cell_type	15	NMOD	I-cell_type
O	O	O	531	536	blood	blood	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	O	537	546	monocytes	monocyte	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	546	547	.	.	O	.	O	8	P	O

O	O	O	548	557	Treatment	Treatment	B-NP	NN	O	18	SUB	O
O	O	O	558	560	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	561	566	these	these	B-NP	DT	O	4	NMOD	O
O	O	O	567	572	cells	cell	I-NP	NNS	O	2	PMOD	O
O	O	O	573	577	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	578	580	10	10	B-NP	CD	O	17	NMOD	O
O	O	O	580	581	(	(	O	(	O	9	DEP	O
O	O	O	581	582	3	3	B-NP	CD	O	9	DEP	O
O	O	O	582	583	)	)	O	)	O	6	NMOD	O
O	O	O	584	589	units	unit	B-NP	NNS	O	17	NMOD	O
O	O	O	589	590	/	/	O	SYM	O	17	NMOD	O
O	O	O	590	592	ml	ml	B-NP	NN	O	15	NMOD	O
T21	B-Entity	B-Entity	593	598	human	human	I-NP	JJ	O	15	NMOD	O
T21	I-Entity	I-Entity	599	610	recombinant	recombinant	I-NP	JJ	O	15	NMOD	O
T21	I-Entity	I-Entity	611	612	M	M	I-NP	NN	O	17	NMOD	O
T21	I-Entity	I-Entity	612	613	-	-	B-NP	HYPH	O	17	NMOD	O
T21	I-Entity	I-Entity	613	616	CSF	CSF	I-NP	NN	B-protein	5	PMOD	B-protein
O	O	O	617	620	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	621	631	associated	associate	I-VP	VBN	O	18	VC	O
O	O	O	632	636	with	with	B-PP	IN	O	19	VMOD	O
O	O	O	637	642	rapid	rapid	B-NP	JJ	O	23	AMOD	O
O	O	O	643	646	and	and	I-NP	CC	O	23	AMOD	O
O	O	O	647	656	transient	transient	I-NP	JJ	O	24	NMOD	O
O	O	O	657	666	increases	increase	I-NP	NNS	O	20	PMOD	O
O	O	O	667	669	in	in	B-PP	IN	O	24	NMOD	O
T6	B-Protein	B-Protein	670	671	c	c	B-NP	NN	B-RNA	29	NMOD	B-RNA
T6	I-Protein	I-Protein	671	672	-	-	O	HYPH	I-RNA	29	NMOD	I-RNA
T6	I-Protein	I-Protein	672	675	jun	jun	B-NP	NN	I-RNA	29	NMOD	I-RNA
O	O	O	676	680	mRNA	mRNA	I-NP	NN	I-RNA	30	NMOD	I-RNA
O	O	O	681	687	levels	level	I-NP	NNS	O	25	PMOD	O
O	O	O	687	688	.	.	O	.	O	18	P	O

O	O	O	689	696	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD	O
O	O	O	697	700	run	run	I-NP	NN	O	9	NMOD	O
O	O	O	700	701	-	-	B-ADVP	HYPH	O	2	P	O
O	O	O	701	703	on	on	B-PP	IN	O	2	NMOD	O
O	O	O	704	710	assays	assay	B-NP	NNS	O	4	PMOD	O
O	O	O	711	714	and	and	O	CC	O	9	NMOD	O
O	O	O	715	719	mRNA	mRNA	B-NP	NN	O	9	NMOD	O
O	O	O	720	729	stability	stability	I-NP	NN	O	9	NMOD	O
O	O	O	730	737	studies	study	I-NP	NNS	O	10	SUB	O
O	O	O	738	750	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	751	755	that	that	B-SBAR	IN	O	10	VMOD	O
T22	B-Entity	B-Entity	756	757	M	M	B-NP	NN	O	14	NMOD	O
T22	I-Entity	I-Entity	757	758	-	-	B-NP	HYPH	O	14	NMOD	O
T22	I-Entity	I-Entity	758	761	CSF	CSF	I-NP	NN	B-protein	15	SUB	B-protein
O	O	O	762	771	regulates	regulate	B-VP	VBZ	O	11	SBAR	O
T7	B-Protein	B-Protein	772	773	c	c	B-NP	NN	B-DNA	19	NMOD	B-DNA
T7	I-Protein	I-Protein	773	774	-	-	O	HYPH	I-DNA	19	NMOD	I-DNA
T7	I-Protein	I-Protein	774	777	jun	jun	B-NP	NN	I-DNA	19	NMOD	I-DNA
O	O	O	778	788	expression	expression	I-NP	NN	O	15	OBJ	O
O	O	O	789	791	by	by	B-PP	IN	O	15	VMOD	O
O	O	O	792	796	both	both	O	CC	O	29	NMOD	O
O	O	O	797	799	an	an	B-NP	DT	O	23	NMOD	O
O	O	O	800	808	increase	increase	I-NP	NN	O	29	NMOD	O
O	O	O	809	811	in	in	B-PP	IN	O	23	NMOD	O
O	O	O	812	825	transcription	transcription	B-NP	NN	O	26	NMOD	O
O	O	O	826	830	rate	rate	I-NP	NN	O	24	PMOD	O
O	O	O	831	834	and	and	O	CC	O	29	NMOD	O
O	O	O	835	836	a	a	B-NP	DT	O	29	NMOD	O
O	O	O	837	849	prolongation	prolongation	I-NP	NN	O	20	PMOD	O
O	O	O	850	852	in	in	B-PP	IN	O	29	NMOD	O
O	O	O	853	856	the	the	B-NP	DT	O	34	NMOD	O
O	O	O	857	861	half	half	I-NP	JJ	O	34	NMOD	O
O	O	O	861	862	-	-	I-NP	HYPH	O	34	NMOD	O
O	O	O	862	866	life	life	I-NP	NN	O	30	PMOD	O
O	O	O	867	869	of	of	B-PP	IN	O	34	NMOD	O
T8	B-Protein	B-Protein	870	871	c	c	B-NP	NN	O	39	NMOD	O
T8	I-Protein	I-Protein	871	872	-	-	O	HYPH	O	39	P	O
T8	I-Protein	I-Protein	872	875	jun	jun	B-NP	NN	B-RNA	39	NMOD	B-RNA
O	O	O	876	887	transcripts	transcript	I-NP	NNS	I-RNA	35	PMOD	I-RNA
O	O	O	887	888	.	.	O	.	O	10	P	O

T23	B-Entity	B-Entity	889	890	M	M	B-NP	NN	O	4	NMOD	O
T23	I-Entity	I-Entity	890	891	-	-	I-NP	HYPH	O	4	NMOD	O
T23	I-Entity	I-Entity	891	894	CSF	CSF	I-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	895	904	treatment	treatment	I-NP	NN	O	5	SUB	O
O	O	O	905	908	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	909	913	also	also	I-VP	RB	O	5	VMOD	O
O	O	O	914	924	associated	associate	I-VP	VBN	O	5	VC	O
O	O	O	925	929	with	with	B-PP	IN	O	7	VMOD	O
O	O	O	930	931	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	932	937	rapid	rapid	I-NP	JJ	O	11	NMOD	O
O	O	O	938	947	induction	induction	I-NP	NN	O	8	PMOD	O
O	O	O	948	950	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	951	954	the	the	B-NP	DT	O	17	NMOD	O
T9	B-Protein	B-Protein	955	958	jun	jun	I-NP	NN	B-DNA	17	NMOD	B-DNA
T9	I-Protein	I-Protein	958	959	-	-	B-NP	HYPH	I-DNA	17	NMOD	I-DNA
T9	I-Protein	I-Protein	959	960	B	B	I-NP	NN	I-DNA	17	NMOD	I-DNA
O	O	O	961	965	gene	gene	I-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	O	965	966	,	,	O	,	O	7	P	O
O	O	O	967	975	although	although	B-SBAR	IN	O	7	VMOD	O
O	O	O	976	986	expression	expression	B-NP	NN	O	24	SUB	O
O	O	O	987	989	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	990	994	this	this	B-NP	DT	O	23	NMOD	O
O	O	O	995	999	gene	gene	I-NP	NN	O	21	PMOD	O
O	O	O	1000	1003	was	be	B-VP	VBD	O	19	SBAR	O
O	O	O	1004	1013	prolonged	prolong	I-VP	VBN	O	24	VC	O
O	O	O	1014	1022	compared	compare	B-VP	VBN	O	25	VMOD	O
O	O	O	1023	1025	to	to	B-PP	TO	O	26	VMOD	O
O	O	O	1026	1030	that	that	B-NP	DT	O	27	PMOD	O
O	O	O	1031	1033	of	of	B-PP	IN	O	28	NMOD	O
T10	B-Protein	B-Protein	1034	1035	c	c	B-NP	NN	B-DNA	32	NMOD	B-DNA
T10	I-Protein	I-Protein	1035	1036	-	-	I-NP	HYPH	I-DNA	32	NMOD	I-DNA
T10	I-Protein	I-Protein	1036	1039	jun	jun	I-NP	NN	I-DNA	29	PMOD	I-DNA
O	O	O	1039	1040	.	.	O	.	O	5	P	O

O	O	O	1041	1043	We	We	B-NP	PRP	O	3	SUB	O
O	O	O	1044	1051	further	further	B-ADVP	RB	O	3	VMOD	O
O	O	O	1052	1063	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	1064	1068	that	that	B-SBAR	IN	O	3	VMOD	O
T24	B-Entity	B-Entity	1069	1070	M	M	B-NP	NN	O	7	NMOD	O
T24	I-Entity	I-Entity	1070	1071	-	-	B-NP	HYPH	O	7	NMOD	O
T24	I-Entity	I-Entity	1071	1074	CSF	CSF	I-NP	NN	B-protein	8	SUB	B-protein
O	O	O	1075	1084	increases	increase	B-VP	VBZ	O	4	SBAR	O
T11	B-Protein	B-Protein	1085	1086	c	c	B-NP	NN	B-RNA	13	NMOD	B-RNA
T11	I-Protein	I-Protein	1086	1087	-	-	I-NP	HYPH	I-RNA	13	NMOD	I-RNA
T11	I-Protein	I-Protein	1087	1090	fos	fos	I-NP	NN	I-RNA	13	NMOD	I-RNA
O	O	O	1091	1095	mRNA	mRNA	I-NP	NN	I-RNA	13	NMOD	I-RNA
O	O	O	1096	1102	levels	level	I-NP	NNS	O	8	OBJ	O
O	O	O	1103	1105	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	1106	1111	human	human	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	O	1112	1121	monocytes	monocyte	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	1122	1129	through	through	B-PP	IN	O	8	VMOD	O
O	O	O	1130	1137	control	control	B-NP	NN	O	17	PMOD	O
O	O	O	1138	1140	at	at	B-PP	IN	O	18	NMOD	O
O	O	O	1141	1145	both	both	B-NP	CC	O	25	NMOD	O
O	O	O	1146	1149	the	the	I-NP	DT	O	25	NMOD	O
O	O	O	1150	1165	transcriptional	transcriptional	I-NP	JJ	O	24	AMOD	O
O	O	O	1166	1169	and	and	I-NP	CC	O	24	AMOD	O
O	O	O	1170	1189	posttranscriptional	posttranscriptional	I-NP	JJ	O	25	NMOD	O
O	O	O	1190	1196	levels	level	I-NP	NNS	O	19	PMOD	O
O	O	O	1196	1197	.	.	O	.	O	3	P	O

O	O	O	1198	1205	Maximal	Maximal	B-NP	JJ	O	2	NMOD	O
O	O	O	1206	1215	induction	induction	I-NP	NN	O	9	SUB	O
O	O	O	1216	1218	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1219	1222	the	the	B-NP	DT	O	8	NMOD	O
T12	B-Protein	B-Protein	1223	1224	c	c	I-NP	NN	B-DNA	8	NMOD	B-DNA
T12	I-Protein	I-Protein	1224	1225	-	-	B-NP	HYPH	I-DNA	8	NMOD	I-DNA
T12	I-Protein	I-Protein	1225	1228	fos	fos	I-NP	NN	I-DNA	8	NMOD	I-DNA
O	O	O	1229	1233	gene	gene	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	O	1234	1237	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1238	1246	followed	follow	I-VP	VBN	O	9	VC	O
O	O	O	1247	1249	by	by	B-PP	IN	O	10	VMOD	O
O	O	O	1250	1254	that	that	B-NP	DT	O	11	PMOD	O
O	O	O	1255	1258	for	for	B-PP	IN	O	12	NMOD	O
O	O	O	1259	1262	the	the	B-NP	DT	O	18	NMOD	O
T13	B-Protein	B-Protein	1263	1266	fos	fos	I-NP	NN	B-DNA	18	NMOD	B-DNA
T13	I-Protein	I-Protein	1266	1267	-	-	I-NP	HYPH	I-DNA	18	NMOD	I-DNA
T13	I-Protein	I-Protein	1267	1268	B	B	I-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	O	1269	1273	gene	gene	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	O	1273	1274	.	.	O	.	O	9	P	O

O	O	O	1275	1283	Moreover	Moreover	B-ADVP	RB	O	20	VMOD	O
O	O	O	1283	1284	,	,	O	,	O	20	P	O
T25	B-Entity	B-Entity	1285	1286	M	M	B-NP	NN	O	8	NMOD	O
T25	I-Entity	I-Entity	1286	1287	-	-	B-NP	HYPH	O	8	NMOD	O
T25	I-Entity	I-Entity	1287	1290	CSF	CSF	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1290	1291	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	O	1291	1298	induced	induce	I-NP	VBN	O	8	NMOD	O
O	O	O	1299	1309	expression	expression	I-NP	NN	O	20	SUB	O
O	O	O	1310	1312	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1313	1316	the	the	B-NP	DT	O	14	NMOD	O
T26	B-Entity	B-Entity	1317	1320	fos	fos	I-NP	NN	B-DNA	14	NMOD	B-DNA
T26	I-Entity	I-Entity	1320	1321	-	-	B-NP	HYPH	I-DNA	14	NMOD	I-DNA
T26	I-Entity	I-Entity	1321	1328	related	relate	I-NP	VBN	I-DNA	14	NMOD	I-DNA
T26	I-Entity	I-Entity	1329	1333	gene	gene	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	O	1333	1334	,	,	O	,	O	17	P	O
T14	B-Protein	B-Protein	1335	1338	fra	fra	B-NP	NN	B-DNA	17	NMOD	B-DNA
T14	I-Protein	I-Protein	1338	1339	-	-	B-NP	HYPH	I-DNA	14	P	I-DNA
T14	I-Protein	I-Protein	1339	1340	1	1	I-NP	CD	I-DNA	14	NMOD	I-DNA
O	O	O	1340	1341	,	,	O	,	O	8	P	O
O	O	O	1342	1345	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1346	1353	delayed	delay	I-VP	VBN	O	20	VC	O
O	O	O	1354	1362	compared	compare	B-VP	VBN	O	21	VMOD	O
O	O	O	1363	1365	to	to	B-PP	TO	O	22	PMOD	O
O	O	O	1366	1370	that	that	B-NP	DT	O	23	PMOD	O
O	O	O	1371	1374	for	for	B-PP	IN	O	24	NMOD	O
O	O	O	1375	1379	both	both	O	CC	O	33	NMOD	O
T15	B-Protein	B-Protein	1380	1381	c	c	B-NP	NN	B-DNA	29	NMOD	B-DNA
T15	I-Protein	I-Protein	1381	1382	-	-	B-NP	HYPH	I-DNA	29	NMOD	I-DNA
T15	I-Protein	I-Protein	1382	1385	fos	fos	I-NP	NN	I-DNA	33	NMOD	I-DNA
O	O	O	1386	1389	and	and	I-NP	CC	O	33	NMOD	O
T16	B-Protein	B-Protein	1390	1393	fos	fos	I-NP	NN	O	33	NMOD	O
T16	I-Protein	I-Protein	1393	1394	-	-	O	HYPH	O	33	P	O
T16	I-Protein	I-Protein	1394	1395	B	B	B-NP	NN	O	25	PMOD	O
O	O	O	1395	1396	.	.	O	.	O	20	P	O

O	O	O	1397	1402	Taken	Take	B-VP	VBN	O	6	VMOD	O
O	O	O	1403	1411	together	together	B-ADVP	RB	O	1	VMOD	O
O	O	O	1411	1412	,	,	O	,	O	6	P	O
O	O	O	1413	1416	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1417	1424	results	result	I-NP	NNS	O	6	SUB	O
O	O	O	1425	1433	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1434	1438	that	that	B-SBAR	IN	O	27	DEP	O
T27	B-Entity	B-Entity	1439	1440	M	M	B-NP	NN	O	11	NMOD	O
T27	I-Entity	I-Entity	1440	1441	-	-	B-NP	HYPH	O	11	NMOD	O
T27	I-Entity	I-Entity	1441	1444	CSF	CSF	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	1445	1454	treatment	treatment	I-NP	NN	O	12	SUB	O
O	O	O	1455	1457	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	O	1458	1468	associated	associate	I-VP	VBN	O	12	VC	O
O	O	O	1469	1473	with	with	B-PP	IN	O	13	VMOD	O
O	O	O	1474	1486	differential	differential	B-NP	JJ	O	16	NMOD	O
O	O	O	1487	1497	activation	activation	I-NP	NN	O	14	PMOD	O
O	O	O	1498	1500	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1501	1509	multiple	multiple	B-NP	JJ	O	19	NMOD	O
O	O	O	1510	1517	members	member	I-NP	NNS	O	17	PMOD	O
O	O	O	1518	1520	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	1521	1524	the	the	B-NP	DT	O	25	NMOD	O
T28	B-Entity	B-Entity	1525	1528	jun	jun	I-NP	NN	B-protein	25	NMOD	B-protein
T28	I-Entity	I-Entity	1528	1529	/	/	B-VP	SYM	I-protein	25	NMOD	I-protein
T28	I-Entity	I-Entity	1529	1532	fos	fos	B-NP	NN	I-protein	25	NMOD	I-protein
T28	I-Entity	I-Entity	1533	1539	family	family	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	O	1540	1543	and	and	O	CC	O	27	DEP	O
O	O	O	1544	1548	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	1549	1559	expression	expression	B-NP	NN	O	32	SUB	O
O	O	O	1560	1562	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	1563	1568	these	these	B-NP	DT	O	31	NMOD	O
O	O	O	1569	1574	genes	gene	I-NP	NNS	O	29	PMOD	O
O	O	O	1575	1580	could	could	B-VP	MD	O	27	SBAR	O
O	O	O	1581	1591	contribute	contribute	I-VP	VB	O	32	VC	O
O	O	O	1592	1594	to	to	B-PP	TO	O	33	VMOD	O
O	O	O	1595	1602	nuclear	nuclear	B-NP	JJ	O	37	NMOD	O
O	O	O	1603	1612	signaling	signaling	I-NP	NN	O	37	NMOD	O
O	O	O	1613	1623	mechanisms	mechanism	I-NP	NNS	O	34	PMOD	O
O	O	O	1624	1628	that	that	B-NP	WDT	O	37	NMOD	O
O	O	O	1629	1637	regulate	regulate	B-VP	VBP	O	38	SBAR	O
O	O	O	1638	1639	a	a	B-NP	DT	O	42	NMOD	O
O	O	O	1640	1648	specific	specific	I-NP	JJ	O	42	NMOD	O
O	O	O	1649	1656	program	program	I-NP	NN	O	39	OBJ	O
O	O	O	1657	1659	of	of	B-PP	IN	O	42	NMOD	O
O	O	O	1660	1668	monocyte	monocyte	B-NP	NN	O	45	NMOD	O
O	O	O	1669	1684	differentiation	differentiation	I-NP	NN	O	43	PMOD	O
O	O	O	1684	1685	.	.	O	.	O	6	P	O
